Philipp Oster
Lyon, 69007, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Modeling antibody persistence after MenACYW-TT vaccination and comparative analysis with other quadrivalent meningococcal vaccines.
Journal: Scientific reports
Published: December 18, 2024
Immune persistence and booster response of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) 5 years after primary vaccination of adults at ≥56 years of age.
Journal: Human vaccines & immunotherapeutics
Published: November 18, 2024
Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered as a booster to adults aged ≥59 years: A phase III randomized study.
Journal: Human vaccines & immunotherapeutics
Published: January 12, 2023
Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age.
Journal: Human vaccines & immunotherapeutics
Published: August 10, 2022
Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial.
Journal: Human vaccines & immunotherapeutics
Published: April 21, 2022
Risk Factors for Contracting Invasive Meningococcal Disease and Related Mortality: A Systematic Literature Review and Meta-analysis.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 31, 2022
Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.
Journal: BMC public health
Published: September 30, 2021
A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT.
Journal: Expert review of vaccines
Published: August 09, 2021
Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study.
Journal: Human vaccines & immunotherapeutics
Published: December 03, 2020
Immunogenicity and Safety of a Two-Dose Series of a Meningococcal (Groups A, C, W, and Y) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Men-ACWY-D) in Healthy Japanese Adults.
Journal: Japanese journal of infectious diseases
Published: November 02, 2020
Post-Marketing Surveillance Observational Study of Quadrivalent Meningococcal Diphtheria Toxoid Conjugate Vaccine (MenACWY-DT, MCV4/Menactra®) in the Republic of Korea, 2014-2019.
Journal: Infectious diseases and therapy
Published: October 29, 2020
Last Updated: 09/26/2026